• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Increased nuchal translucency linked to progesterone therapy

byDenise PongandLeah Hawkins Bressler, MD, MPH
October 12, 2014
in Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Women receiving progesterone therapy in the first trimester were more likely to have fetuses with increased nuchal translucency at 11-14 weeks gestation.

2. Formulation, dosage and route of administration of progesterone were not associated with significant differences in NT.

Evidence Rating Level: 2 (Good)  

Study Rundown: Nuchal translucency (NT) is a biomarker used in pregnancy in conjunction with maternal beta human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) levels to screen for Down syndrome. NT uses ultrasound to measure the thickness of the translucent space at the posterior fetal neck at 10-14 weeks. The combination of NT, β-hCG and PAPP-A is able to detect 85% of fetuses with Down syndrome, with a false positive rate of 5% and is superior to the use of NT alone.

While evidence supporting the use of progesterone therapy is limited to women using assisted reproductive technology (ART) and those with a history of or at high risk for preterm birth, it remains common practice to also use progesterone to prevent miscarriage and treat threatened abortion. Prior work suggests progesterone may influence vascular smooth muscle relaxation and alter placental blood flow. In the present work, authors found that progesterone therapy was associated with increased NT levels. This finding represents the first clinical evidence that exogenous progesterone may directly affect the developing fetus.

Limitations of the study include observational design, which precludes the authors’ assumption of causality between progesterone therapy and increased NT, and exclusion of women with chronic health issues, limiting the generalizability of the study results. Findings call for exploration of the implied associations herein, with particular attention paid to determining whether progesterone-related increases in NT are also associated with an increased risk of Down syndrome in offspring.

Click to read the study in AJOG

RELATED REPORTS

Prenatal administration of novel compound treats Down syndrome in mice [PreClinical]

Non-invasive prenatal testing linked to decreased diagnostic testing

2 Minute Medicine Rewind March 28 – April 5, 2015

Relevant Reading: Ultrasound screening for fetal major abnormalities at 11-14 weeks

In-Depth [prospective cohort study]: This study evaluated NT at 11-14 weeks gestation among 1090 women receiving progesterone therapy for ART, prevention of miscarriage and treatment of threatened abortion, and 2626 women not receiving progesterone treatment. The primary outcome of interest was NT.

Nuchal translucency was higher among women in the progesterone treatment group (p<0.05). A similar relationship was observed among women at low risk for aneuploidy and other fetal abnormalities, defined as women with NT < 2.5mm (p < 0.05). Formulation, dosage and route of administration of progesterone were not associated with significant differences in NT.

More from this author: Venous thromboembolism after vaginal delivery rising- preventative measures lacking, Unexpected delivery outcomes associated with postpartum depression, Postoperative pain similar in robotic and conventional laparoscopy for gynecologic procedures, Intrahepatic cholestasis of pregnancy linked to poor outcomes, Severe acne linked to endometriosis

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: Down syndromenuchal translucencyprenatal testingTrisomy 21
Previous Post

Robotic adnexal surgeries may have more complications than laparoscopic

Next Post

Albumin in cirrhotic patients with spontaneous bacterial peritonitis [Classics Series]

RelatedReports

Non-invasive prenatal testing linked to decreased diagnostic testing
Chronic Disease

Prenatal administration of novel compound treats Down syndrome in mice [PreClinical]

October 9, 2017
Non-invasive prenatal testing linked to decreased diagnostic testing
Obstetrics

Non-invasive prenatal testing linked to decreased diagnostic testing

September 13, 2015
2 Minute Medicine Rewind November 23 – November 30, 2014
Chronic Disease

2 Minute Medicine Rewind March 28 – April 5, 2015

April 7, 2015
Health A to Z

Patient Basics: Down Syndrome

November 30, 2014
Next Post
Classics Series, Landmark Trials in Medicine

Albumin in cirrhotic patients with spontaneous bacterial peritonitis [Classics Series]

Probiotic formulations do not prevent antibiotic-associated diarrhea

Frozen fecal transplant effective for Clostridium difficile infection

ACP endorses polysomnography over portable monitors for diagnosing sleep apnea

Sleeping on sofas linked to mortality in infants

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events
  • Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia
  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.